TET2 and breast carcinoma: As a result, this study provides a role for TET2 that underlies breast cancer resistance to anti-estrogen treatments, and our in vivo Tet2 deletion breast cancer mouse model will be a valuable tool for studying the associated mechanism(s) for development of anti-cancer therapies.